Trials / Completed
CompletedNCT04921306
Obese Human Beta-2-adrenergic Stimulation and Muscle Glucose Uptake
Targeting the Beta-2-adrenergic Pathway to Improve Skeletal Muscle Glucose Uptake in Obese Humans
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Maastricht University · Academic / Other
- Sex
- All
- Age
- 40 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate the effect of four weeks clenbuterol/placebo supplementation on skeletal muscle glucose disposal in overweight/obese male and (postmenopausal) female volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Clenbuterol Hydrochloride | Daily ingestion of clenbuterol hydrochloride capsules (40 microgram/day) for a total period of 28 days with a wash-out period of at least 6-8 weeks. |
| DRUG | Placebo | Daily ingestion of placebo capsules for a total period of 28 days with a wash-out period of at least 6-8 weeks. |
Timeline
- Start date
- 2022-08-16
- Primary completion
- 2024-03-01
- Completion
- 2024-03-01
- First posted
- 2021-06-10
- Last updated
- 2024-05-07
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT04921306. Inclusion in this directory is not an endorsement.